symbol,statement_type,period_end,line_item,value
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Tax Rate For Calcs,0.255778
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Normalized EBITDA,2669200000.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Total Unusual Items,0.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,1609900000.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Reconciled Depreciation,443300000.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Reconciled Cost Of Revenue,8627400000.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,EBITDA,2669200000.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,EBIT,2225900000.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Net Interest Income,-62700000.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Interest Expense,62700000.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Interest Income,
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Normalized Income,1609900000.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,1609900000.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Total Expenses,11564200000.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Rent Expense Supplemental,
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Diluted Average Shares,91679954.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Basic Average Shares,91679954.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Diluted EPS,17.56
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Basic EPS,17.56
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Diluted NI Availto Com Stockholders,1609900000.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Net Income Common Stockholders,1609900000.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Net Income,1609900000.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Net Income Including Noncontrolling Interests,1609900000.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Net Income Continuous Operations,1609900000.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Tax Provision,553300000.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Pretax Income,2163200000.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Other Non Operating Income Expenses,226500000.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Special Income Charges,0.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Other Special Charges,
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Net Non Operating Interest Income Expense,-62700000.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Total Other Finance Cost,
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Interest Expense Non Operating,62700000.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Interest Income Non Operating,
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Operating Income,1999400000.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Operating Expense,2936800000.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Other Operating Expenses,2493500000.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Depreciation And Amortization In Income Statement,443300000.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Amortization,
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Depreciation Income Statement,443300000.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Selling General And Administration,
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Selling And Marketing Expense,
INDRAMEDCO.NS,income,2025-03-31 00:00:00,General And Administrative Expense,
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Rent And Landing Fees,
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Gross Profit,4936200000.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Cost Of Revenue,8627400000.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Total Revenue,13563600000.0
INDRAMEDCO.NS,income,2025-03-31 00:00:00,Operating Revenue,13563600000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Tax Rate For Calcs,0.253748
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Normalized EBITDA,2102500000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Total Unusual Items,0.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,1239600000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Reconciled Depreciation,400800000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Reconciled Cost Of Revenue,7905900000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,EBITDA,2102500000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,EBIT,1701700000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Net Interest Income,-40600000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Interest Expense,40600000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Interest Income,168900000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Normalized Income,1239600000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,1239600000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Total Expenses,10914200000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Rent Expense Supplemental,23500000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Diluted Average Shares,91686391.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Basic Average Shares,91686391.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Diluted EPS,13.52
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Basic EPS,13.52
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Diluted NI Availto Com Stockholders,1239600000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Net Income Common Stockholders,1239600000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Net Income,1239600000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Net Income Including Noncontrolling Interests,1239600000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Net Income Continuous Operations,1239600000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Tax Provision,421500000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Pretax Income,1661100000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Other Non Operating Income Expenses,168900000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Special Income Charges,0.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Other Special Charges,11700000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Net Non Operating Interest Income Expense,-40600000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Total Other Finance Cost,30000000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Interest Expense Non Operating,40600000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Interest Income Non Operating,168900000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Operating Income,1532800000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Operating Expense,3008300000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Other Operating Expenses,2607500000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Depreciation And Amortization In Income Statement,400800000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Amortization,6200000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Depreciation Income Statement,400800000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Selling General And Administration,1159700000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Selling And Marketing Expense,1042200000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,General And Administrative Expense,117500000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Rent And Landing Fees,23500000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Gross Profit,4541100000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Cost Of Revenue,7905900000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Total Revenue,12447000000.0
INDRAMEDCO.NS,income,2024-03-31 00:00:00,Operating Revenue,12447000000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Tax Effect Of Unusual Items,-2303814.644137
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Tax Rate For Calcs,0.264806
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Normalized EBITDA,1577800000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Total Unusual Items,-8700000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-8700000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,861500000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Reconciled Depreciation,392700000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Reconciled Cost Of Revenue,7203000000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,EBITDA,1569100000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,EBIT,1176400000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Net Interest Income,57500000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Interest Expense,4600000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Interest Income,100300000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Normalized Income,867896185.355863
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,861500000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Total Expenses,9526500000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Rent Expense Supplemental,21900000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Diluted Average Shares,91673000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Basic Average Shares,91673000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Diluted EPS,9.4
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Basic EPS,9.4
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Diluted NI Availto Com Stockholders,861500000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Net Income Common Stockholders,861500000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Net Income,861500000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Net Income Including Noncontrolling Interests,861500000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Net Income Continuous Operations,861500000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Tax Provision,310300000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Pretax Income,1171800000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Other Non Operating Income Expenses,100300000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Special Income Charges,-8700000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Other Special Charges,8700000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Net Non Operating Interest Income Expense,57500000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Total Other Finance Cost,38200000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Interest Expense Non Operating,4600000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Interest Income Non Operating,100300000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Operating Income,1123000000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Operating Expense,2323500000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Other Operating Expenses,1252900000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Depreciation And Amortization In Income Statement,392700000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Amortization,14300000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Depreciation Income Statement,378400000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Selling General And Administration,969600000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Selling And Marketing Expense,872700000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,General And Administrative Expense,96900000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Rent And Landing Fees,21900000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Gross Profit,3446500000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Cost Of Revenue,7203000000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Total Revenue,10649500000.0
INDRAMEDCO.NS,income,2023-03-31 00:00:00,Operating Revenue,10649500000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Tax Effect Of Unusual Items,-14923042.873403
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Tax Rate For Calcs,0.258632
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Normalized EBITDA,1203900000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Total Unusual Items,-57700000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-57700000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,586200000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Reconciled Depreciation,349400000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Reconciled Cost Of Revenue,5971600000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,EBITDA,1146200000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,EBIT,796800000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Net Interest Income,-2900000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Interest Expense,6100000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Interest Income,31200000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Normalized Income,628976957.126597
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,586200000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Total Expenses,7770100000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Rent Expense Supplemental,18600000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Diluted Average Shares,91673000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Basic Average Shares,91673000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Diluted EPS,6.39
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Basic EPS,6.39
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Diluted NI Availto Com Stockholders,586200000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Net Income Common Stockholders,586200000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Net Income,586200000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Net Income Including Noncontrolling Interests,586200000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Net Income Continuous Operations,586200000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Tax Provision,204500000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Pretax Income,790700000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Other Non Operating Income Expenses,31200000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Special Income Charges,-57700000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Other Special Charges,57700000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Net Non Operating Interest Income Expense,-2900000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Total Other Finance Cost,28000000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Interest Expense Non Operating,6100000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Interest Income Non Operating,31200000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Operating Income,851300000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Operating Expense,1798500000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Other Operating Expenses,1071800000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Depreciation And Amortization In Income Statement,349400000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Amortization,
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Depreciation Income Statement,349400000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Selling General And Administration,602100000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Selling And Marketing Expense,533500000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,General And Administrative Expense,68600000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Rent And Landing Fees,18600000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Gross Profit,2649800000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Cost Of Revenue,5971600000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Total Revenue,8621400000.0
INDRAMEDCO.NS,income,2022-03-31 00:00:00,Operating Revenue,8621400000.0
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Tax Effect Of Unusual Items,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Tax Rate For Calcs,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Normalized EBITDA,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Total Unusual Items,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Total Unusual Items Excluding Goodwill,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Reconciled Depreciation,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Reconciled Cost Of Revenue,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,EBITDA,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,EBIT,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Net Interest Income,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Interest Expense,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Interest Income,6800000.0
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Normalized Income,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Total Expenses,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Rent Expense Supplemental,20100000.0
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Diluted Average Shares,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Basic Average Shares,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Diluted EPS,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Basic EPS,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Diluted NI Availto Com Stockholders,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Net Income Common Stockholders,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Otherunder Preferred Stock Dividend,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Net Income,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Net Income Including Noncontrolling Interests,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Net Income Continuous Operations,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Tax Provision,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Pretax Income,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Other Non Operating Income Expenses,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Special Income Charges,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Other Special Charges,7100000.0
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Net Non Operating Interest Income Expense,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Total Other Finance Cost,33400000.0
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Interest Expense Non Operating,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Interest Income Non Operating,6800000.0
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Operating Income,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Operating Expense,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Other Operating Expenses,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Depreciation And Amortization In Income Statement,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Amortization,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Depreciation Income Statement,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Selling General And Administration,320900000.0
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Selling And Marketing Expense,264400000.0
INDRAMEDCO.NS,income,2021-03-31 00:00:00,General And Administrative Expense,56500000.0
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Rent And Landing Fees,20100000.0
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Gross Profit,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Cost Of Revenue,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Total Revenue,
INDRAMEDCO.NS,income,2021-03-31 00:00:00,Operating Revenue,
